Stephens Inc’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,765
Closed -$23K 1310
2022
Q1
$23K Sell
10,765
-7,649
-42% -$18.6K ﹤0.01% 1299
2021
Q4
$68K Sell
18,414
-1,000
-5% -$4.3K ﹤0.01% 1271
2021
Q3
$97K Hold
19,414
﹤0.01% 1270
2021
Q2
$127K Buy
19,414
+5,266
+37% +$36.8K ﹤0.01% 1247
2021
Q1
$97K Buy
14,148
+1,000
+8% +$8.45K ﹤0.01% 1224
2020
Q4
$134K Sell
13,148
-1,000
-7% -$6.48K ﹤0.01% 1124
2020
Q3
$50K Sell
14,148
-131
-0.9% -$622 ﹤0.01% 1128
2020
Q2
$71K Sell
14,279
-14,500
-50% -$49.3K ﹤0.01% 1068
2020
Q1
$98K Buy
28,779
+12,000
+72% +$51.8K ﹤0.01% 982
2019
Q4
$92K Buy
16,779
+5,092
+44% +$28.7K ﹤0.01% 1075
2019
Q3
$67K Sell
11,687
-8,800
-43% -$59.8K ﹤0.01% 1119
2019
Q2
$157K Buy
20,487
+320
+2% +$1.72K ﹤0.01% 1101
2019
Q1
$106K Sell
20,167
-2,905
-13% -$20.1K ﹤0.01% 1118
2018
Q4
$151K Sell
23,072
-76,208
-77% -$854K ﹤0.01% 1020
2018
Q3
$1.71M Buy
+99,280
New +$1.48M 0.04% 434
2017
Q3
Sell
-90,159
Closed -$2.17M 833
2017
Q2
$2.17M Buy
90,159
+3,089
+4% +$67.7K 0.07% 278
2017
Q1
$1.73M Buy
87,070
+9,204
+12% +$205K 0.06% 319
2016
Q4
$1.88M Buy
77,866
+1,498
+2% +$41.7K 0.08% 275
2016
Q3
$2.12M Buy
76,368
+12,344
+19% +$326K 0.09% 235
2016
Q2
$1.56M Buy
64,024
+16,491
+35% +$468K 0.07% 289
2016
Q1
$1.6M Buy
47,533
+27,202
+134% +$856K 0.08% 266
2015
Q4
$608K Buy
20,331
+4,843
+31% +$163K 0.03% 406
2015
Q3
$488K Sell
15,488
-404
-3% -$19.7K 0.03% 453
2015
Q2
$769K Buy
15,892
+1,714
+12% +$72.2K 0.03% 405
2015
Q1
$615K Buy
14,178
+576
+4% +$20.7K 0.03% 462
2014
Q4
$358K Buy
13,602
+2,092
+18% +$45.9K 0.02% 580
2014
Q3
$204K Buy
+11,510
New +$235K 0.01% 713

Other funds holding PGEN

Stephens Inc's PGEN Position: Q2 2022 in Review

Stephens Inc sold out of Precigen (PGEN) in Q2 2022, closing a stake of 10,765 shares — an estimated $23K sold.

Stephens Inc first reported a position in PGEN in Q3 2014 and held it in 27 quarters. The position peaked at $2.17M in Q2 2017. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Stephens Inc reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Stephens Inc sold 10,765 Precigen shares in Q2 2022, an estimated $23K.
  • Stephens Inc first reported a position in Precigen in Q3 2014 and held it in 27 quarters.
  • Stephens Inc's Precigen position peaked at $2.17M in Q2 2017.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Stephens Inc's 13F filing for Q2 2022, filed 3 Aug 2022.